MORGUARD LINCLUDEN GLOBAL INVESTMENTS Ltd historic quarter change: Foreign Stocks, Added
In share positions in stocks (depositary receipts and foreign shares traded over the counter), over 23 quarters from 2013-06-30 to 2026-06-30, MORGUARD LINCLUDEN GLOBAL INVESTMENTS Ltd opened 8 positions, added to 72, reduced 80 and sold out of 8.
- Q2 2026: Stock SHEL; Country of operation —; Class SPON ADR; Shares before 33,038.
- Q1 2026: Stock SAP; Country of operation —; Class SPON ADR; Shares before 27,410.
- Q1 2026: Stock ING; Country of operation —; Class SPON ADR; Shares before 208,280.
- Q1 2026: Stock DEO; Country of operation —; Class SPON ADR NEW; Shares before 99,706.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1058231), 23 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-07-24); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-13); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-01-30); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-07-25); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-06); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-04); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-10-28); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-07-24); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-07); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-17); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-23); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-04-21); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-09); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-07-31); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-05); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-19); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-21); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-07-18); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-04-16); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-11); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-13). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2006-03-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q2 2026 | SHEL
SHELL PLC | | SPON ADR | 33,038 | 50,952 | +17,914 | $3,072 | $3,951 | +$879 | 2026-07-24 |
|---|
| Q1 2026 | SAP
SAP SE | | SPON ADR | 27,410 | 29,833 | +2,423 | $6,658 | $5,107 | -$1,551 | 2026-05-13 |
|---|
| Q1 2026 | ING
ING GROEP N V | | SPON ADR | 208,280 | 218,394 | +10,114 | $5,832 | $5,689 | -$143 | 2026-05-13 |
|---|
| Q1 2026 | DEO
DIAGEO PLC-SPONS ADR | | SPON ADR NEW | 99,706 | 114,963 | +15,257 | $8,602 | $8,558 | -$44 | 2026-05-13 |
|---|
| Q4 2025 | DEO
DIAGEO PLC-SPONS ADR | | SPON ADR NEW | 57,835 | 99,706 | +41,871 | $5,519 | $8,602 | +$3,083 | 2026-01-30 |
|---|
| Q4 2025 | GSK
GSK PLC | | SPONSORED ADR | 61,480 | 100,877 | +39,397 | $2,653 | $3,533 | +$880 | 2026-01-30 |
|---|
| Q3 2025 | SAP
SAP SE | | SPON ADR | 5,106 | 27,439 | +22,333 | $1,553 | $7,332 | +$5,779 | 2025-11-14 |
|---|
| Q2 2025 | GRTUF
GRANITE REAL ESTATE INVT TR | Canada | UNIT | 101,364 | 112,144 | +10,780 | $4,723 | $5,692 | +$969 | 2025-07-25 |
|---|
| Q1 2025 | DEO
DIAGEO PLC-SPONS ADR | | SPON ADR NEW | 57,739 | 58,498 | +759 | $7,340 | $6,130 | -$1,210 | 2025-05-06 |
|---|
| Q4 2024 | GSK
GSK PLC | | SPONSORED ADR | 66,001 | 66,128 | +127 | $2,698 | $2,236 | -$462 | 2025-02-04 |
|---|
| Q4 2024 | ORANY
ORANGE | France | SPON ADR | 290,222 | 290,392 | +170 | $3,332 | $2,895 | -$437 | 2025-02-04 |
|---|
| Q3 2024 | DEO
DIAGEO PLC-SPONS ADR | | SPON ADR NEW | 50,600 | 58,070 | +7,470 | $6,380 | $8,150 | +$1,770 | 2024-10-28 |
|---|
| Q3 2024 | ING
ING GROEP N V | | SPON ADR | 311,475 | 314,117 | +2,642 | $5,339 | $5,704 | +$365 | 2024-10-28 |
|---|
| Q3 2024 | GSK
GSK PLC | | SPONSORED ADR | 65,168 | 66,001 | +833 | $2,509 | $2,698 | +$189 | 2024-10-28 |
|---|
| Q2 2024 | ORANY
ORANGE | France | SPON ADR | 268,004 | 322,909 | +54,905 | $3,154 | $3,226 | +$72 | 2024-07-24 |
|---|
| Q3 2016 | SAP
SAP SE | | SPON ADR | 92,838 | 93,283 | +445 | $6,965,000 | $8,527,000 | +$1,562,000 | 2016-11-17 |
|---|
| Q3 2016 | BCS
BARCLAYS PLC | | ADR | 164,524 | 217,064 | +52,540 | $1,250,000 | $1,886,000 | +$636,000 | 2016-11-17 |
|---|
| Q3 2016 | ABBNY
ABB LTD. | Switzerland | SPON ADR | 140,291 | 142,471 | +2,180 | $2,782,000 | $3,207,000 | +$425,000 | 2016-11-17 |
|---|
| Q3 2016 | TEVA
TEVA PHARMACEUTICAL INDS LTD. | | ADR | 53,847 | 54,582 | +735 | $2,705,000 | $2,511,000 | -$194,000 | 2016-11-17 |
|---|
| Q3 2016 | SNY
SANOFI AVENTIS | | SPON ADR | 67,551 | 68,966 | +1,415 | $2,827,000 | $2,634,000 | -$193,000 | 2016-11-17 |
|---|
| Q3 2016 | ORANY
ORANGE | France | SPON ADR | 172,016 | 175,576 | +3,560 | $2,825,000 | $2,735,000 | -$90,000 | 2016-11-17 |
|---|
| Q2 2016 | SNY
SANOFI AVENTIS | | SPON ADR | 56,442 | 67,551 | +11,109 | $2,267,000 | $2,827,000 | +$560,000 | 2016-08-23 |
|---|
| Q2 2016 | ABBNY
ABB LTD. | Switzerland | SPON ADR | 118,543 | 140,291 | +21,748 | $2,302,000 | $2,782,000 | +$480,000 | 2016-08-23 |
|---|
| Q2 2016 | ING
ING GROEP N V | | SPON ADR | 251,839 | 255,118 | +3,279 | $3,004,000 | $2,635,000 | -$369,000 | 2016-08-23 |
|---|
| Q2 2016 | ORANY
ORANGE | France | SPON ADR | 142,861 | 172,016 | +29,155 | $2,483,000 | $2,825,000 | +$342,000 | 2016-08-23 |
|---|
| Q2 2016 | TEVA
TEVA PHARMACEUTICAL INDS LTD. | | ADR | 45,830 | 53,847 | +8,017 | $2,452,000 | $2,705,000 | +$253,000 | 2016-08-23 |
|---|
| Q2 2016 | BCS
BARCLAYS PLC | | ADR | 161,122 | 164,524 | +3,402 | $1,389,000 | $1,250,000 | -$139,000 | 2016-08-23 |
|---|
| Q2 2016 | SAP
SAP SE | | SPON ADR | 86,833 | 92,838 | +6,005 | $6,983,000 | $6,965,000 | -$18,000 | 2016-08-23 |
|---|
| Q1 2016 | BCS
BARCLAYS PLC | | ADR | 157,112 | 161,122 | +4,010 | $2,036,000 | $1,389,000 | -$647,000 | 2016-04-21 |
|---|
| Q1 2016 | TEVA
TEVA PHARMACEUTICAL INDS LTD. | | ADR | 45,780 | 45,830 | +50 | $3,005,000 | $2,452,000 | -$553,000 | 2016-04-21 |
|---|
| Q1 2016 | ABBNY
ABB LTD. | Switzerland | SPON ADR | 99,998 | 118,543 | +18,545 | $1,767,000 | $2,302,000 | +$535,000 | 2016-04-21 |
|---|
| Q1 2016 | ING
ING GROEP N V | | SPON ADR | 250,709 | 251,839 | +1,130 | $3,375,000 | $3,004,000 | -$371,000 | 2016-04-21 |
|---|
| Q1 2016 | ORANY
ORANGE | France | SPON ADR | 142,841 | 142,861 | +20 | $2,375,000 | $2,483,000 | +$108,000 | 2016-04-21 |
|---|
| Q1 2016 | SNY
SANOFI AVENTIS | | SPON ADR | 55,392 | 56,442 | +1,050 | $2,362,000 | $2,267,000 | -$95,000 | 2016-04-21 |
|---|
| Q4 2015 | BCS
BARCLAYS PLC | | ADR | 148,832 | 157,112 | +8,280 | $2,200,000 | $2,036,000 | -$164,000 | 2016-02-12 |
|---|
| Q4 2015 | SNY
SANOFI AVENTIS | | SPON ADR | 47,632 | 55,392 | +7,760 | $2,261,000 | $2,362,000 | +$101,000 | 2016-02-12 |
|---|
| Q4 2015 | ING
ING GROEP N V | | SPON ADR | 235,439 | 250,709 | +15,270 | $3,327,000 | $3,375,000 | +$48,000 | 2016-02-12 |
|---|
| Q3 2015 | ULXXXX
UNILEVER | | SPON ADR | 6,190 | 166,640 | +160,450 | $266,000 | $4,562,000 | +$4,296,000 | 2015-11-09 |
|---|
| Q3 2015 | SAP
SAP SE | | SPON ADR | 42,078 | 88,023 | +45,945 | $2,955,000 | $5,703,000 | +$2,748,000 | 2015-11-09 |
|---|
| Q1 2015 | TEVA
TEVA PHARMACEUTICAL INDS LTD. | | ADR | 53,670 | 67,540 | +13,870 | $3,087,000 | $4,208,000 | +$1,121,000 | 2015-05-05 |
|---|
| Q1 2015 | SAP
SAP AG | | SPON ADR | 37,318 | 49,923 | +12,605 | $2,599,000 | $3,603,000 | +$1,004,000 | 2015-05-05 |
|---|
| Q4 2014 | SNY
SANOFI AVENTIS | | SPON ADR | 56,187 | 63,527 | +7,340 | $3,171,000 | $2,897,000 | -$274,000 | 2015-02-19 |
|---|
| Q3 2014 | ORANY
ORANGE | France | SPON ADR | 698,356 | 702,196 | +3,840 | $11,034,000 | $10,350,000 | -$684,000 | 2014-11-21 |
|---|
| Q3 2014 | SNY
SANOFI AVENTIS | | SPON ADR | 55,137 | 56,187 | +1,050 | $2,932,000 | $3,171,000 | +$239,000 | 2014-11-21 |
|---|
| Q3 2014 | TEVA
TEVA PHARMACEUTICAL INDS LTD. | | ADR | 79,114 | 80,923 | +1,809 | $4,147,000 | $4,350,000 | +$203,000 | 2014-11-21 |
|---|
| Q3 2014 | SAP
SAP AG | | SPON ADR | 37,553 | 38,263 | +710 | $2,892,000 | $2,761,000 | -$131,000 | 2014-11-21 |
|---|
| Q3 2014 | ING
ING GROEP N V | | SPON ADR | 386,884 | 390,874 | +3,990 | $5,424,000 | $5,547,000 | +$123,000 | 2014-11-21 |
|---|
| Q3 2014 | BCS
BARCLAYS PLC | | ADR | 210,132 | 214,267 | +4,135 | $3,070,000 | $3,173,000 | +$103,000 | 2014-11-21 |
|---|
| Q3 2014 | ABBNY
ABB LTD. | Switzerland | SPON ADR | 140,613 | 143,128 | +2,515 | $3,237,000 | $3,207,000 | -$30,000 | 2014-11-21 |
|---|
| Q3 2014 | PBR
PETROLEO BRASILEIRO | | SPON ADR | 121,857 | 123,962 | +2,105 | $1,783,000 | $1,759,000 | -$24,000 | 2014-11-21 |
|---|
| Q2 2014 | ORANY
ORANGE | France | SPON ADR | 671,606 | 698,356 | +26,750 | $9,866,000 | $11,034,000 | +$1,168,000 | 2014-07-18 |
|---|
| Q2 2014 | TEVA
TEVA PHARMACEUTICAL INDS LTD. | | ADR | 69,596 | 79,114 | +9,518 | $3,677,000 | $4,147,000 | +$470,000 | 2014-07-18 |
|---|
| Q2 2014 | PBR
PETROLEO BRASILEIRO | | SPON ADR | 105,442 | 121,857 | +16,415 | $1,387,000 | $1,783,000 | +$396,000 | 2014-07-18 |
|---|
| Q2 2014 | SNY
SANOFI AVENTIS | | SPON ADR | 49,002 | 55,137 | +6,135 | $2,562,000 | $2,932,000 | +$370,000 | 2014-07-18 |
|---|
| Q2 2014 | ING
ING GROEP N V | | SPON ADR | 356,034 | 386,884 | +30,850 | $5,073,000 | $5,424,000 | +$351,000 | 2014-07-18 |
|---|
| Q2 2014 | SAP
SAP AG | | SPON ADR | 33,373 | 37,553 | +4,180 | $2,714,000 | $2,892,000 | +$178,000 | 2014-07-18 |
|---|
| Q2 2014 | BCS
BARCLAYS PLC | | ADR | 186,712 | 210,132 | +23,420 | $2,931,000 | $3,070,000 | +$139,000 | 2014-07-18 |
|---|
| Q2 2014 | ABBNY
ABB LTD. | Switzerland | SPON ADR | 124,783 | 140,613 | +15,830 | $3,218,000 | $3,237,000 | +$19,000 | 2014-07-18 |
|---|
| Q1 2014 | ORANY
ORANGE | France | SPON ADR | 664,036 | 671,606 | +7,570 | $8,201,000 | $9,866,000 | +$1,665,000 | 2014-04-16 |
|---|
| Q1 2014 | BCS
BARCLAYS PLC | | ADR | 180,593 | 186,712 | +6,119 | $3,274,000 | $2,931,000 | -$343,000 | 2014-04-16 |
|---|
| Q1 2014 | SIEGY
SIEMENS AG | | SPON ADR | 23,349 | 25,679 | +2,330 | $3,234,000 | $3,471,000 | +$237,000 | 2014-04-16 |
|---|
| Q1 2014 | SAP
SAP AG | | SPON ADR | 32,240 | 33,373 | +1,133 | $2,809,000 | $2,714,000 | -$95,000 | 2014-04-16 |
|---|
| Q1 2014 | SNY
SANOFI AVENTIS | | SPON ADR | 47,218 | 49,002 | +1,784 | $2,532,000 | $2,562,000 | +$30,000 | 2014-04-16 |
|---|
| Q1 2014 | ABBNY
ABB LTD. | Switzerland | SPON ADR | 120,133 | 124,783 | +4,650 | $3,191,000 | $3,218,000 | +$27,000 | 2014-04-16 |
|---|
| Q1 2014 | PBR
PETROLEO BRASILEIRO | | SPON ADR | 101,835 | 105,442 | +3,607 | $1,403,000 | $1,387,000 | -$16,000 | 2014-04-16 |
|---|
| Q4 2013 | ING
ING GROEP N V | | SPON ADR | 339,540 | 357,720 | +18,180 | $3,854,000 | $5,012,000 | +$1,158,000 | 2014-02-11 |
|---|
| Q4 2013 | SAP
SAP AG | | SPON ADR | 29,780 | 32,240 | +2,460 | $2,201,000 | $2,809,000 | +$608,000 | 2014-02-11 |
|---|
| Q4 2013 | ABBNY
ABB LTD. | Switzerland | SPON ADR | 110,903 | 120,133 | +9,230 | $2,616,000 | $3,191,000 | +$575,000 | 2014-02-11 |
|---|
| Q4 2013 | BCS
BARCLAYS PLC | | ADR | 166,758 | 180,593 | +13,835 | $2,842,000 | $3,274,000 | +$432,000 | 2014-02-11 |
|---|
| Q4 2013 | TEVA
TEVA PHARMACEUTICAL INDS LTD. | | ADR | 73,891 | 80,098 | +6,207 | $2,792,000 | $3,210,000 | +$418,000 | 2014-02-11 |
|---|
| Q4 2013 | SNY
SANOFI AVENTIS | | SPON ADR | 43,583 | 47,218 | +3,635 | $2,207,000 | $2,532,000 | +$325,000 | 2014-02-11 |
|---|
| Q3 2013 | SAP
SAP AG | | SPON ADR | 28,840 | 29,780 | +940 | $2,100,000 | $2,201,000 | +$101,000 | 2013-11-13 |
|---|